Sunitinib 50mgCapsule
Anti-Cancer

Sunitinib 50mg

Sunitinib Malate

Sunitigen (Sunitinib 50mg) is an anti-cancer medicine that works by blocking cell surface proteins (tyrosine kinases) responsible for cancer growth and restricting tumor blood vessel development. It is used for advanced renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. Available in 12.5mg, 25mg, and 50mg capsules for global pharmaceutical export.

Strengths

12.5mg / 25mg / 50mg

Packing

28 capsules/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Sunitinib Malate 12.5mg / 25mg / 50mg
Dosage Form
Capsule
Available Strengths
12.5mg / 25mg / 50mg
Packing
28 capsules/bottle
Route of Administration
Oral, with or without food
Dosage
50mg once daily for 4 weeks on / 2 weeks off (6-week cycle) for RCC and GIST
Indications
Advanced renal cell carcinoma, gastrointestinal stromal tumor after imatinib failure, advanced pancreatic neuroendocrine tumors
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C
Shelf Life
36 months
Side Effects
Diarrhea, fatigue, nausea, mucositis, hypertension, skin discoloration, hand-foot syndrome, bleeding
Precautions
Monitor blood pressure, thyroid function, and cardiac function; risk of hemorrhage; hepatotoxicity possible; dose adjustment may be needed with CYP3A4 inhibitors/inducers

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sorafenib 200mgTablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg
Lenalidomide 25mgCapsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg
Imatinib 400mgTablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Sunitinib 50mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote